Monday, March 24, 2025 11:56:55 PM
Sohm shares break the ground with failure to commercialize ABBIE kits, hitting 5 year lows of .0004.
Shareholders writhe in disgust over mismanagement of shareholder value.
David and Baron, you're welcome to use the above as follow up headlines for the next PR.
Groundbreaking .0004.
But we're glad you're hiring new warehouse and "marketing" personnel so that you can ship out gummies, and tubes of whatever. Growth? What a disappointment. .0004. Criticism where due.
_____
SOHM, Inc. Shares Groundbreaking Findings in ABBIE Technology
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Shares-Groundbreaking-Findings-in-ABBIE-Technology?id=470061
Shareholders writhe in disgust over mismanagement of shareholder value.
David and Baron, you're welcome to use the above as follow up headlines for the next PR.
Groundbreaking .0004.
But we're glad you're hiring new warehouse and "marketing" personnel so that you can ship out gummies, and tubes of whatever. Growth? What a disappointment. .0004. Criticism where due.
_____
SOHM, Inc. Shares Groundbreaking Findings in ABBIE Technology
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Shares-Groundbreaking-Findings-in-ABBIE-Technology?id=470061
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
